AltRx and Medvi prescribe the same GLP-1 medications — so what really separates them is the care around the prescription. AltRx is our pick for best value; Medvi, for best for simple glp-1 access. Here's how they stack up, category by category.
Bottom line: AltRx wins
AltRx edges it on cost and speed, making it our pick for the tightest budgets. Medvi is just behind and worth it if you want a slightly more guided choice between semaglutide and tirzepatide. Genuinely close.
Round by round
We scored both programs on the six things that actually decide a weight-loss plan. AltRx takes 3, Medvi takes 2, with 1 even. Here's how each category shook out.
Clinical support
How much real clinician time, messaging and follow-up you get. Medvi scores 8.4 to 8.0 — a step ahead.
Medication access
The range of GLP-1 options and how easily the plan adapts. Medvi scores 8.9 to 8.6 — a step ahead.
Value
What you get for the money, judged against comparable programs. AltRx scores 9.5 to 8.7 — clearly ahead.
Onboarding
How quickly and painlessly you can get started. AltRx scores 9.1 to 8.8 — a step ahead.
App & tracking
The quality of the day-to-day tools. AltRx scores 8.2 to 8.0 — just ahead.
Transparency
How clearly pricing and terms are laid out up front. AltRx and Medvi are evenly matched.
Where they differ most
The clearest daylight between them shows up in value, where AltRx leads 9.5 to 8.7 and clinical support, where Medvi leads 8.4 to 8.0. Zoom out and the split is simple: AltRx is our pick for best value, while Medvi earns Medvi's place as best for simple glp-1 access.
On app & tracking and transparency, there's little to separate them — both land within a couple of tenths, so those categories won't decide your choice.
Pricing: AltRx vs Medvi
AltRx is the more budget-friendly of the two ($, budget), while Medvi sits higher ($$, mid-range). Remember that prices move constantly and depend on your dose, so treat the tiers as a guide and confirm the current number with each provider. The figure that matters is the total monthly cost once you reach your maintenance dose — a cheap starter price can climb. We unpack this in how much compounded semaglutide costs.
The specs, side by side
| AltRx | Medvi | |
|---|---|---|
| Editor rating | 8.6/10 · Great | 8.5/10 · Great |
| Best for | Best value | Best for simple GLP-1 access |
| Clinician support | Good | Solid |
| Medication access | Solid | Strong |
| Ease of starting | Strong | Strong |
| Value for money | Extensive | Strong |
| Typical price | $ · Budget | $$ · Mid-range |
Which should you pick?
Choose Medvi if…
You want a clean, guided choice between semaglutide and tirzepatide.
View Medvi plans →Common questions
Is AltRx better than Medvi?
In our scoring, AltRx comes out ahead — 8.6/10 to 8.5/10, winning 3 of the six categories we rate. That makes it our pick for most people. Medvi is still the better choice if you want a clean, guided choice between semaglutide and tirzepatide.
Which is cheaper, AltRx or Medvi?
AltRx is the cheaper option. AltRx is the more budget-friendly of the two ($, budget), while Medvi sits higher ($$, mid-range). Whichever you lean toward, compare the total cost at your maintenance dose — not just the introductory price.
Do AltRx and Medvi prescribe the same medications?
Both work from the same GLP-1 toolkit — semaglutide and/or tirzepatide, branded or compounded depending on the plan. On medication access and flexibility, Medvi scores a little higher in our review. Availability of any specific product shifts over time, so confirm current options with each provider.
Which has better clinician support, AltRx or Medvi?
Medvi edges ahead on clinical support in our scoring — that's the depth of real clinician time and follow-up you get. Both include a genuine medical review; the difference is how much ongoing access comes with it.
Are AltRx and Medvi legit?
Both meet the bar we score for: a real evaluation by a licensed clinician before any prescription, clear medication information, and a way to reach someone with questions. Neither should issue a GLP-1 without a proper review.
Which has the better app, AltRx or Medvi?
AltRx has the edge on day-to-day tools and tracking in our scoring. If living in an app and logging progress matters to you, that's worth weighing; if you mostly want the medication handled, it matters less.
Can I switch between AltRx and Medvi?
Generally, yes. Neither program locks you into a long contract, so if you start with one and it isn't the right fit you can move to the other. Just never stop or change a GLP-1 medication without talking to your clinician first.
Our pick: AltRx
AltRx came out ahead across our scoring. Check its current plans and offer directly with the provider.
View AltRx plans →Both programs are scored with the same independent methodology. We may earn a commission from either provider — it changes nothing about the scores or the verdict. Pricing tiers are relative; confirm current prices with each provider. Nothing here is medical advice.